V CompBrief BY VELARION

Independent Director · Seres Therapeutics, Inc. (MCRB)

Robert Rosiello director compensation at Seres Therapeutics: $147K

Fiscal year 2025 director compensation for Robert Rosiello at Seres Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 27, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Robert Rosiello’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Robert Rosiello and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Seres Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Seres Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$21,257$0$125,858$0$147,115

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Seres Therapeutics, Inc. DEF 14A filed April 27, 2026, accession 0001193125-26-182036, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Seres Therapeutics, Inc. filed document, accession 0001193125-26-182036. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.

Get the Seres Therapeutics Board Governance Report

$147,115 Robert Rosiello, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 27, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Seres Therapeutics pays directors a $45,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Compensation

The rest of the Seres Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Claire M. Fraser, Ph.DIndependent Director$151,688
Dennis A. Ausiello, M.DIndependent Director$131,688
Eric D. ShaffDirector—
Hans-Juergen Woerle, M.D., Ph.DIndependent Director$132,362
Kurt C. GravesIndependent Director$88,375
Richard N. KenderChair of the Board$123,375
Stephen A. BerensonIndependent Director$168,985
Willard H. Dere, M.DIndependent Director$113,375

The full Seres Therapeutics compensation record

free company brief
Seres Therapeutics, Inc. (MCRB) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within Seres Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Seres Therapeutics proxy · each links to its own free brief

Order MCRB

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report